Unrecognized Tax Benefits of LIGAND PHARMACEUTICALS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
LIGAND PHARMACEUTICALS INC quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • LIGAND PHARMACEUTICALS INC Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $27,644,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $27,644,000 +$5,173,000 +23% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $19,865,000 +$5,384,000 +37% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $14,316,000 -$166,000 -1.1% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $14,189,000 +$142,000 +1% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $22,471,000 +$108,000 +0.48% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $14,481,000 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $14,482,000 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $14,047,000 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $22,363,000 -$6,733,000 -23% 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q4 2022 $29,096,000 -$454,000 -1.5% 31 Dec 2022 10-K 27 Feb 2026 2025 FY
Q4 2021 $29,550,000 -$2,069,000 -6.5% 31 Dec 2021 10-K 28 Feb 2025 2024 FY
Q4 2020 $31,619,000 +$2,972,000 +10% 31 Dec 2020 10-K 29 Feb 2024 2023 FY
Q4 2019 $28,647,000 -$1,642,000 -5.4% 31 Dec 2019 10-K 28 Feb 2023 2022 FY
Q4 2018 $30,289,000 +$926,000 +3.2% 31 Dec 2018 10-K 28 Feb 2022 2021 FY
Q4 2017 $29,363,000 -$9,407,000 -24% 31 Dec 2017 10-K 24 Feb 2021 2020 FY
Q4 2016 $38,770,000 +$2,318,000 +6.4% 31 Dec 2016 10-K 27 Feb 2020 2019 FY
Q3 2016 $33,500,000 +$25,200,000 +304% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $33,900,000 30 Jun 2016 10-Q 14 Nov 2016 2016 Q2
Q1 2016 $33,600,000 31 Mar 2016 10-Q 14 Nov 2016 2016 Q1
Q4 2015 $36,452,000 +$27,928,000 +328% 31 Dec 2015 10-K 28 Feb 2019 2018 FY
Q3 2015 $8,300,000 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q4 2014 $8,524,000 +$20,000 +0.24% 31 Dec 2014 10-K 01 Mar 2018 2017 FY
Q4 2013 $8,504,000 +$437,000 +5.4% 31 Dec 2013 10-K 28 Feb 2017 2016 FY
Q4 2012 $8,067,000 -$839,000 -9.4% 31 Dec 2012 10-K 23 Feb 2015 2014 FY
Q4 2011 $8,906,000 +$85,000 +0.96% 31 Dec 2011 10-K/A 12 Dec 2014 2013 FY
Q4 2010 $8,821,000 31 Dec 2010 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.